Omnicell, Inc. (OMCL)
USD 44.18
(-2.28%)
USD 44.18
(-2.28%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 60.69 Million USD | -21.29% |
| 2022 | 96.84 Million USD | -44.48% |
| 2021 | 174.43 Million USD | 62.84% |
| 2020 | 107.12 Million USD | -24.81% |
| 2019 | 78.35 Million USD | 48.81% |
| 2018 | 95.74 Million USD | 67.19% |
| 2017 | 62.65 Million USD | -11.69% |
| 2016 | 64.84 Million USD | -3.77% |
| 2015 | 71.88 Million USD | 35.9% |
| 2014 | 69.85 Million USD | 40.47% |
| 2013 | 53.66 Million USD | 30.34% |
| 2012 | 40.45 Million USD | 65.59% |
| 2011 | 24.13 Million USD | 43.35% |
| 2010 | 18.58 Million USD | 310.99% |
| 2009 | 10.63 Million USD | -80.11% |
| 2008 | 29.69 Million USD | -38.95% |
| 2007 | 22.82 Million USD | 77.36% |
| 2006 | 12.97 Million USD | 471.92% |
| 2005 | 2.15 Million USD | -84.92% |
| 2004 | 15.02 Million USD | 20.61% |
| 2003 | 11.44 Million USD | 521.25% |
| 2002 | -5.9 Million USD | -33.34% |
| 2001 | 1.89 Million USD | 129.75% |
| 2000 | -12.97 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q3 | -29.3 Million USD | -74.78% |
| 2024 Q1 | 4.49 Million USD | 272.14% |
| 2024 Q2 | 26.03 Million USD | 1848.43% |
| 2023 Q1 | 1.25 Million USD | 109.16% |
| 2023 Q3 | 27.26 Million USD | -14.27% |
| 2023 Q4 | 72.19 Million USD | 164.76% |
| 2023 Q2 | 31.8 Million USD | 2426.21% |
| 2023 FY | - USD | -21.29% |
| 2022 Q1 | 29.51 Million USD | -14.74% |
| 2022 Q3 | 43.19 Million USD | 14.07% |
| 2022 Q2 | 37.87 Million USD | 28.31% |
| 2022 Q4 | -13.74 Million USD | -131.81% |
| 2022 FY | - USD | -44.48% |
| 2021 Q4 | 34.61 Million USD | -31.51% |
| 2021 Q3 | 50.54 Million USD | 2.72% |
| 2021 Q2 | 49.2 Million USD | 22.76% |
| 2021 FY | - USD | 62.84% |
| 2021 Q1 | 40.08 Million USD | -0.33% |
| 2020 Q3 | 27.81 Million USD | 172.12% |
| 2020 Q2 | 10.22 Million USD | -64.61% |
| 2020 Q1 | 28.87 Million USD | -25.69% |
| 2020 FY | - USD | -24.81% |
| 2020 Q4 | 40.21 Million USD | 44.6% |
| 2019 Q2 | 34.62 Million USD | 23.66% |
| 2019 FY | - USD | 48.81% |
| 2019 Q4 | 38.86 Million USD | -5.19% |
| 2019 Q1 | 28 Million USD | -14.61% |
| 2019 Q3 | 40.98 Million USD | 18.38% |
| 2018 Q1 | 12.94 Million USD | -54.82% |
| 2018 Q3 | 30.15 Million USD | 51.9% |
| 2018 Q4 | 32.79 Million USD | 8.73% |
| 2018 FY | - USD | 67.19% |
| 2018 Q2 | 19.85 Million USD | 53.39% |
| 2017 Q3 | 22.31 Million USD | 1028.2% |
| 2017 Q1 | -4.78 Million USD | -133.54% |
| 2017 FY | - USD | -11.69% |
| 2017 Q4 | 28.64 Million USD | 28.39% |
| 2017 Q2 | -2.4 Million USD | 49.79% |
| 2016 Q4 | 14.27 Million USD | -27.3% |
| 2016 FY | - USD | -3.77% |
| 2016 Q3 | 19.63 Million USD | 34.44% |
| 2016 Q2 | 14.6 Million USD | -10.53% |
| 2016 Q1 | 16.32 Million USD | -14.76% |
| 2015 FY | - USD | 35.9% |
| 2015 Q4 | 19.15 Million USD | -5.84% |
| 2015 Q3 | 20.33 Million USD | 267.26% |
| 2015 Q2 | 5.53 Million USD | -46.64% |
| 2015 Q1 | 10.37 Million USD | -22.97% |
| 2014 Q4 | 13.47 Million USD | -0.9% |
| 2014 FY | - USD | 40.47% |
| 2014 Q1 | 9.95 Million USD | -9.96% |
| 2014 Q2 | 12.55 Million USD | 26.16% |
| 2014 Q3 | 13.59 Million USD | 8.27% |
| 2013 Q4 | 11.05 Million USD | 3.15% |
| 2013 Q2 | 9.35 Million USD | 124.49% |
| 2013 Q3 | 10.71 Million USD | 14.51% |
| 2013 Q1 | 4.16 Million USD | -57.42% |
| 2013 FY | - USD | 30.34% |
| 2012 Q1 | 3.53 Million USD | -43.25% |
| 2012 Q2 | 2.5 Million USD | -29.25% |
| 2012 Q3 | 11.19 Million USD | 346.96% |
| 2012 Q4 | 9.79 Million USD | -12.52% |
| 2012 FY | - USD | 65.59% |
| 2011 Q2 | 4.15 Million USD | 326.56% |
| 2011 Q4 | 6.23 Million USD | 25.1% |
| 2011 FY | - USD | 43.35% |
| 2011 Q1 | 975 Thousand USD | -69.54% |
| 2011 Q3 | 4.98 Million USD | 19.86% |
| 2010 Q3 | 5.15 Million USD | 49.99% |
| 2010 Q2 | 3.43 Million USD | 139.65% |
| 2010 Q1 | 1.43 Million USD | -69.39% |
| 2010 FY | - USD | 310.99% |
| 2010 Q4 | 3.2 Million USD | -37.94% |
| 2009 Q2 | 1.12 Million USD | -47.33% |
| 2009 FY | - USD | -80.11% |
| 2009 Q3 | 888 Thousand USD | -20.93% |
| 2009 Q1 | 2.13 Million USD | -82.79% |
| 2009 Q4 | 4.68 Million USD | 427.93% |
| 2008 Q3 | 5.6 Million USD | -8.8% |
| 2008 Q2 | 6.14 Million USD | -11.93% |
| 2008 Q1 | 6.98 Million USD | -38.37% |
| 2008 Q4 | 12.38 Million USD | 121.0% |
| 2008 FY | - USD | -38.95% |
| 2007 Q3 | 4.12 Million USD | -19.09% |
| 2007 Q2 | 5.09 Million USD | 16.72% |
| 2007 Q1 | 4.36 Million USD | -34.37% |
| 2007 Q4 | 11.32 Million USD | 174.64% |
| 2007 FY | - USD | 77.36% |
| 2006 FY | - USD | 471.92% |
| 2006 Q1 | 1.93 Million USD | -32.64% |
| 2006 Q2 | 2.17 Million USD | 12.47% |
| 2006 Q3 | 2.91 Million USD | 34.19% |
| 2006 Q4 | 6.65 Million USD | 128.19% |
| 2005 Q4 | 2.86 Million USD | 22.83% |
| 2005 FY | - USD | -84.92% |
| 2005 Q3 | 2.33 Million USD | 125.82% |
| 2005 Q1 | -3.98 Million USD | -211.48% |
| 2005 Q2 | 1.03 Million USD | 125.97% |
| 2004 Q2 | 3.75 Million USD | 12.71% |
| 2004 Q1 | 3.32 Million USD | -22.9% |
| 2004 FY | - USD | 20.61% |
| 2004 Q4 | 3.57 Million USD | -16.85% |
| 2004 Q3 | 4.29 Million USD | 14.5% |
| 2003 Q4 | 3.99 Million USD | 29.94% |
| 2003 Q3 | 2.5 Million USD | -8.41% |
| 2003 Q2 | 2.99 Million USD | 222.49% |
| 2003 Q1 | 382 Thousand USD | 303.23% |
| 2003 FY | - USD | 521.25% |
| 2002 Q3 | -2.89 Million USD | -190.22% |
| 2002 Q4 | -8.28 Million USD | 112.55% |
| 2002 Q1 | 1.37 Million USD | -4.9% |
| 2002 Q2 | 1.71 Million USD | 22.04% |
| 2002 FY | - USD | -33.34% |
| 2001 FY | - USD | 129.75% |
| 2001 Q1 | -310 Thousand USD | 0.0% |
| 2001 Q3 | 457 Thousand USD | 1483.54% |
| 2001 Q4 | 2.12 Million USD | 69.7% |
| 2001 Q2 | 79 Thousand USD | 125.48% |
| 2000 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Inovalon Holdings, Inc. | 186.56 Million USD | 67.469% |
| GE HealthCare Technologies Inc. | 3.56 Billion USD | 98.295% |
| Sharecare, Inc. | -67.25 Million USD | 190.24% |
| Progyny, Inc. | 64.46 Million USD | 5.856% |
| Aclarion, Inc. | -4.14 Million USD | 1565.796% |
| CareMax, Inc. | -590.46 Million USD | 110.278% |
| Simulations Plus, Inc. | 6.13 Million USD | -889.887% |
| CareCloud, Inc. | -31.29 Million USD | 293.96% |
| Forian Inc. | 2.75 Million USD | -2106.676% |
| Bullfrog AI Holdings, Inc. Warrants | -5.27 Million USD | 1250.509% |
| Bullfrog AI Holdings, Inc. Common Stock | -5.27 Million USD | 1250.509% |
| Minerva Surgical, Inc. | -20.07 Million USD | 402.346% |
| Definitive Healthcare Corp. | -241.22 Million USD | 125.159% |
| Zhongchao Inc. | -4.9 Million USD | 1337.977% |
| Accolade, Inc. | -71.19 Million USD | 185.247% |
| Streamline Health Solutions, Inc. | -12.81 Million USD | 573.549% |
| Ontrak, Inc. | -14.41 Million USD | 520.991% |
| SOPHiA GENETICS SA | -70.7 Million USD | 185.842% |
| R1 RCM Inc. | 426.2 Million USD | 85.76% |
| Spok Holdings, Inc. | 26.29 Million USD | -130.787% |
| Privia Health Group, Inc. | 27.18 Million USD | -123.273% |
| EUDA Health Holdings Limited | -8.3 Million USD | 831.173% |
| HeartBeam, Inc. | 675 Thousand USD | -8891.111% |
| GeneDx Holdings Corp. | -136.46 Million USD | 144.475% |
| TruBridge, Inc. | -15.39 Million USD | 494.321% |
| Nutex Health, Inc. | -14.58 Million USD | 516.216% |
| Renalytix Plc | -28.52 Million USD | 312.791% |
| Sharecare, Inc. | -67.25 Million USD | 190.24% |
| Health Catalyst, Inc. | -66.46 Million USD | 191.315% |
| 10x Genomics, Inc. | -205.11 Million USD | 129.589% |
| GoodRx Holdings, Inc. | 108.82 Million USD | 44.231% |
| SCWorx Corp. | -3.97 Million USD | 1626.91% |
| Schrödinger, Inc. | -171.89 Million USD | 135.306% |
| HealthEquity, Inc. | 282.41 Million USD | 78.51% |
| HealthStream, Inc. | 59.58 Million USD | -1.851% |
| MSP Recovery, Inc. | -69.22 Million USD | 187.676% |
| Augmedix, Inc. | -17.68 Million USD | 443.25% |
| BrightSpring Health Services, Inc. Common Stock | 349.51 Million USD | 82.636% |
| Ontrak, Inc. | -14.41 Million USD | 520.991% |
| SHL Telemedicine Ltd. | 3.28 Million USD | -1748.325% |
| CareCloud, Inc. | -31.29 Million USD | 293.96% |
| Premier, Inc. | 286.08 Million USD | 78.786% |
| Certara, Inc. | 23.84 Million USD | -154.529% |
| GeneDx Holdings Corp. | -136.46 Million USD | 144.475% |
| OneMedNet Corporation | -11.97 Million USD | 606.986% |
| BrightSpring Health Services, Inc. Tangible Equity Unit | 349.51 Million USD | 82.636% |
| EUDA Health Holdings Limited | -8.3 Million USD | 831.173% |
| HeartBeam, Inc. | 675 Thousand USD | -8891.111% |
| CareCloud, Inc. | -31.29 Million USD | 293.96% |
| Mangoceuticals, Inc. | -9.18 Million USD | 760.569% |
| CareMax, Inc. | -590.46 Million USD | 110.278% |
| Healthcare Triangle, Inc. | -4.1 Million USD | 1578.801% |
| National Research Corporation | 45.98 Million USD | -31.978% |
| Aclarion, Inc. | -4.14 Million USD | 1565.796% |
| OptimizeRx Corporation | -21.3 Million USD | 384.817% |